IBOV 180,767.74 ▲ 1.89% IPSA 11,315.26 ▼ 1.14% IPC MEX 65,314.78 ▼ 0.18% MERVAL 3,040,031 ▲ 0.20% COLCAP 2,473.24 ▲ 1.99% BVL PERÚ 59,450.29 ▲ 0.01% USD/BRL5.15▼ 0.61% USD/MXN17.00▲ 0.03% USD/CLP936.18▲ 0.21% USD/COP3,160▼ 1.30% USD/PEN3.36▼ 0.17% USD/ARS1,513▲ 0.25% USD/UYU40.24▲ 0.68% USD/PYG5,873▲ 0.47% USD/BOB12.08▲ 3.98% USD/DOP58.56▲ 0.38% USD/CRC446.47▲ 1.09% USD/GTQ7.62▲ 1.63% USD/HNL26.84▲ 1.11% USD/NIO36.62▲ 0.14% USD/VES796.33▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD 157.28 — 0.00% USD/TTD6.69▼ 0.06% EUR/BRL5.97▼ 0.68% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73% IBOV 180,767.74 ▲ 1.89% IPSA 11,315.26 ▼ 1.14% IPC MEX 65,314.78 ▼ 0.18% MERVAL 3,040,031 ▲ 0.20% COLCAP 2,473.24 ▲ 1.99% BVL PERÚ 59,450.29 ▲ 0.01% USD/BRL 5.16 ▲ 0.01% USD/MXN 17.06 ▼ 0.24% USD/CLP 913.98 ▲ 0.04% USD/COP 3,140 ▲ 0.03% USD/PEN 3.36 ▼ 0.66% USD/ARS 1,493 ▲ 0.10% USD/UYU 40.27 ▲ 1.24% USD/PYG 5,939 ▲ 1.68% USD/BOB 11.64 ▼ 0.76% USD/DOP 58.34 ▲ 1.25% USD/CRC 445.92 ▲ 0.89% USD/GTQ 7.62 ▲ 2.21% USD/HNL 26.79 ▲ 1.57% USD/NIO 36.62 ▲ 0.69% USD/VES 762.44 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.28 — 0.00% USD/TTD 6.70 ▲ 0.61% EUR/BRL 5.95 ▲ 1.01% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73%
since 2009
Tuesday, September 1, 2026

Covid-19 Brazil

Brazil’s next Health Minister vows to continue Bolsonaro’s policies

By · March 16, 2021 · 2 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

RIO DE JANEIRO, BRAZIL – The nominee for Brazil’s health minister, who will represent the ministry’s third change of leadership during the Covid-19 pandemic, said on Tuesday, March 16th, that he plans to continue the policies of right-wing President Jair Bolsonaro.

Brazil's next health minister vows to continue Bolsonaro's policies
Brazil’s next health minister vows to continue Bolsonaro’s policies
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →
RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →

The initial comments by cardiologist Marcelo Queiroga, a day after he was tapped by Bolsonaro, dashed hopes for a change in course to curb a worsening pandemic that has killed over 270,000 people in Brazil, which had the worst weekly death toll in the world last week.

Outgoing Health Minister Eduardo Pazuello, an active-duty army general, was under pressure as fatalities surged, even though he toed Bolsonaro’s line against lockdowns. He also backed the president’s endorsement of anti-malarial drugs to treat COVID-19, the effectiveness of which is disputed by most health care providers.

“Minister Pazuello has been working hard to improve health conditions in Brazil and I was called upon by President Bolsonaro to continue this work,” Queiroga told reporters as he arrived for his first meeting at the ministry.

He said health policy is set by the president and the minister is there to implement it.

The formal appointment of Queiroga, who campaigned for Bolsonaro in 2018 and served on his transition team, is expected on Wednesday. There is no date yet for a handover, although he has begun transition work by meeting with Pazuello.

Queiroga, who is president of the Brazilian Cardiology Society, criticized the use of anti-malarial hydroxychloroquine to treat COVID-19 patients in a newspaper interview on Sunday, saying there was no scientific evidence that it worked, but he added that doctors are free to prescribe the drug.

He also said that lockdowns are not the way to stop the pandemic, repeating Bolsonaro’s position in defiance of most public health experts and state governors in Brazil.

Pazuello, who has no medical degree, had been criticized for lacking public health expertise and rubberstamping Bolsonaro’s decisions. His two predecessors resigned in roughly the span of a month last year, in part because as physicians they would not fully endorse treating patients with hydroxychloroquine.

Pazuello expanded access to the drug, which is unproven as a COVID-19 treatment, and allowed it to be prescribed to virtually anyone testing positive for the novel coronavirus.

His failure to secure timely supplies of vaccines led to calls for an inquiry in Congress, while the Supreme Court is investigating his handling of the pandemic in the city of Manaus, where hospitals ran out of oxygen.

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.